EVENT DETAILS

EVENT DETAILS

Novavax NanoFlu Achieves All Primary Endpoints In Phase 3 Clinical Trial

Mar 24, 2020 at 8:30 AM EDT

Webcast Presentation

Title
Novavax NanoFlu Achieves All Primary Endpoints In Phase 3 Clinical Trial
Date / Time
Mar 24, 2020 at 8:30 AM EDT

This site uses cookies and similar technologies to provide you with our services, enhance the performance and functionality of our services, and analyze the use of our products and services. By clicking ‘Accept’ you are indicating your consent for us to place these cookies. For more information, please read our Privacy Policy or manage your cookie settings.

Accept